American Century Companies’s Climb Bio CLYM Stock Holding History
Bought
Maintained
Sold
Other funds holding CLYM
RCM
B
CAM
FCM
American Century Companies's CLYM Position: Q2 2026 in Review
American Century Companies opened a new position in Climb Bio (CLYM) in Q2 2026: 47,250 shares worth $616K. The stake represents ﹤0.01% of the portfolio and ranks #2539 among its holdings. This is a return to the name: American Century Companies previously reported a position in CLYM as recently as Q4 2024.
American Century Companies first reported a position in CLYM in Q3 2024 and has held it in 3 quarters since. 108 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.
- American Century Companies held 47,250 shares of Climb Bio worth $616K as of Q2 2026.
- Climb Bio was a new American Century Companies position in Q2 2026.
- Climb Bio made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2539 holding.
- American Century Companies first reported a position in Climb Bio in Q3 2024 and has held it in 3 quarters since.
- 108 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.